Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug–Drug Interactions with a Novel Series of Centrally Efficacious BACE1 InhibitorsMichael A. Brodney, Brian T. O’Neill, Eric F. Johnson et al.|Journal of Medicinal Chemistry|2015Cited by 78
Utilizing CYP2D6 and BACE1 Structure Complexes to Reduce Risk of Drug-Drug Interactions with a Novel Series of Centrally Efficacious BACE1 InhibitorsMichael A. Brodney, Brian T. O’Neill, Elizabeth M. Beck et al.|Unknown|2015Cited by 1